A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Clinical trial NCT06872125 · RECRUITING

Trial details

NCT number: NCT06872125
Sponsor: Stoke Therapeutics, Inc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dravet Syndrome

Start date: 2025-06-04
Primary completion: 2027-03-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.